Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
...nts with autoimmunediseases such as systemic lupus erythematosus (SLE) andanti-phospholipid syndrome. The study looked at 113 SLE patients(94 with secondary anti-phospholipid syndrome and 19 without) andconcluded the measurement of anti-AtherOx is significantly betterthan conventional anti-cardiolipin testing in i......ry results. About Lupus Nephritis Systemic lupus erythematosus (SLE), commonly called lupus, is achronic autoimmune disease that causes the body to attack its owntissues and joints. Lupus nephritis, considered life-threatening,but rare, is the most serious manifestation of SLE. If leftuntreated, it can lead to k......lity of life inpatients with active systemic lupus erythematosus (SLE). The52-week and 76-week results of the Phase...About Systemic Lupus Erythematosus Systemic lupus erythematosus (SLE) is a chronic,life-threatening disease. The Lupus Foundation of America estimatesthat approxima...... certain autoimmunediseases such as systemic lupus erythematosus (SLE). Current dataindicates that levels of BLyS and APRIL are elevated in patientswith rheumatoid arthritis, SLE and B-cell malignancies. Atacicepthas been shown to affect several stages of B-cell development andmay inhibit the survival of cells res...... certain autoimmune diseases such as systemiclupus erythematosus (SLE), an indication for which Rituxan has notbeen approved. About Rituxan Rituxan is a therapeutic antibody being studied in primaryprogressive MS, for which there is currently no FDA-approvedtherapy. Rituxan is also being studied in other autoim...... certain autoimmune diseases such as systemiclupus erythematosus (SLE), an indication for which Rituxan has notbeen approved. About Rituxan Rituxan is a therapeutic antibody being studied in primaryprogressive MS, for which there is currently no FDA-approvedtherapy. Rituxan is also being studied in other autoimm......d autoimmune disease. About Lupus Systemic lupus erythematosus (SLE), also called lupus, is anautoimmune disorder characterized by the immune system attackingthe body's own tissues and organs, leading to inflammation anddamage. The severity of the disease varies, from mild cases onlyinvolving the skin to severe ......roduce a clinical picturesimulating systemic lupus erythematosus (SLE) includingglomerulonephritis. If SLE-like symptoms occur, discontinuation ofBiDil should be considered. Residua have been detected many yearsafter discontinuation of hydralazine. Symptomatic hypotension mayoccur with even small doses of BiDil. B...La Jolla Pharmaceutical Provides Update on Interim Antibody Results From Riquent Lupus Phase 3 Trial
... drug candidate for the treatmentof systemic lupus erythematosus ("lupus"), and any other drugcandidate that we may develop, including the results of any trialsor models that are ongoing or that we may initiate in the future,could result in a finding that these drug candidates are noteffective in large patient pop...La Jolla Pharmaceutical Announces Positive Interim Antibody Results From Riquent Lupus Phase 3 Trial
...imus sodium), its drugcandidate for systemic lupus erythematosus ("lupus" or "SLE").Analyses of interim antibody da... drug candidate for the treatmentof systemic lupus erythematosus ("lupus"), and any other drugcandidate that we may develop, including the results of any trialsor mo...